Metronidazole Lotion
PreclinicalSmall molecule
LEO PharmaMetronidazole Lotion is one of 17 small molecule programs targeting Rosacea. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
16
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
17 competitors in Rosacea
#DrugCompanyPhaseTrials
1Vibramycin
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Approved
Alphagan
NovartisApproved
Minocin
TTriax
Approved
Flagyl
DDePuy Orthopaedics
Approved
Avlosulfon
AAlmirall, S.A.
Approved
Retin-a
VValeant Pharmaceuticals
Approved
Stromectol
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Phase 3
Elavil
AstraZenecaPhase 2
Tofranil
SanofiPhase 2
Seysara
AAlmirall, S.A.
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Metronidazole Lotion. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company